<?xml version='1.0' encoding='utf-8'?>
<document id="29466493"><sentence text="Preventable adverse drug events in critically ill HIV patients: Is the detection of potential drug-drug interactions a useful tool?" /><sentence text="The aim of this study was to develop a strategy to identify adverse drug events associated with drug-drug interactions by analyzing the prescriptions of critically ill patients" /><sentence text="" /><sentence text="This retrospective study included HIV/AIDS patients who were admitted to an intensive care unit between November 2006 and September 2008" /><sentence text=" Data were collected in two stages" /><sentence text=" In the first stage, three prescriptions administered throughout the entire duration of these patients' hospitalization were reviewed, with the Micromedex database used to search for potential drug-drug interactions" /><sentence text=" In the second stage, a search for adverse drug events in all available medical, nursing and laboratory records was performed" /><sentence text=" The probability that a drug-drug interaction caused each adverse drug events was assessed using the Naranjo algorithm" /><sentence text="" /><sentence text="A total of 186 drug prescriptions of 62 HIV/AIDS patients were analyzed" /><sentence text=" There were 331 potential drug-drug interactions, and 9% of these potential interactions resulted in adverse drug events in 16 patients; these adverse drug events included treatment failure (16" /><sentence text="7%) and adverse reactions (83" /><sentence text="3%)" /><sentence text=" Most of the adverse drug reactions were classified as possible based on the Naranjo algorithm" /><sentence text="" /><sentence text="The approach used in this study allowed for the detection of adverse drug events related to 9% of the potential drug-drug interactions that were identified; these adverse drug events affected 26% of the study population" /><sentence text=" With the monitoring of adverse drug events based on prescriptions, a combination of the evaluation of potential drug-drug interactions by clinical pharmacy services and the monitoring of critically ill patients is an effective strategy that can be used as a complementary tool for safety assessments and the prevention of adverse drug events" /><sentence text="" /></document>